PharmiWeb.com - Global Pharma News & Resources
14-Sep-2021

Impact of Coronavirus (Covid-19) Pandemic – Proton Therapy Market Is Anticipated To Reach US$ 4,494.0 Mn at a CAGR of 16.7 % By 2027

Proton Therapy Market report includes historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. Proton Therapy Market offers complete, proficient report delivering market research data that is relevant for new market entrants or set up players. Key strategies of the companies operating in the market and their impact analysis have been included in the report.

Global Proton Therapy Market: Drivers

Proton therapy offers several advantages such as precise targeting of tumors and cancer cells, minimal exit dose, reduced overall toxicity, and low number of short- and long-term side effects on surrounding healthy tissues and organs. Such advantages are expected to propel growth of the global proton therapy market over the forecast period.

Global Proton Therapy Market: Opportunities

Increasing funding for cancer research is expected to offer lucrative growth opportunities for players in the market. For instance, according to the National Cancer Research Institute (NCRI), cancer research funding by NCRI partners reached around US$ 750 million in 2018/19.

Request Sample Copy of this report here

Global Proton Therapy Market: Restraints

Side effects of proton therapy are expected to hamper growth of the market. Side effects of proton therapy include, fatigue and skin problems, including redness, irritation, swelling, dryness, or blistering and peeling.

Key Takeaways:

The Multiple Room segment in the global proton therapy market was valued at US$ 1,019.4 Mn in 2019 and is expected to reach US$ 3,513.9 Mn by 2027 at a CAGR of 16.7% during the forecast period. Increasing number of healthcare facilities offering proton therapy is also expected to aid in growth of the segment.

Lung Cancer segment held dominant position in the global proton therapy market in 2019, accounting for 22.1% share in terms of value, followed by Head & Neck Cancer, respectively. Increasing prevalence of cancer is expected to boost growth of the global proton therapy market over the forecast period.

Market Trends

Government organizations are focused on boosting the number of photon therapy centers. For instance, in February 2020, Advanced Oncotherapy announced its plans to install a Linac Image Guided Hadron Technology in collaboration with University Hospitals Birmingham NHS Foundation Trust.

Several studies are concluding positive results regarding the use of proton therapy. For instance, in December 2019, researchers at the Perelman School of Medicine at the University of Pennsylvania reported that proton therapy leads to a significantly lower risk of side effects.

Get Flat USD 2000 OFF

Buy-Now this research report: https://www.coherentmarketinsights.com/promo/buynow/3672

Reasons to Purchase this Report

• Current and future of global Lab-on-a-chip Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Global Proton Therapy Market: Competitive Landscape 

Major players operating in the global proton therapy market include, Hitachi Ltd., Ion Beam Applications SA, Mevion Medical Systems, Mitsubishi Electric Corporation, ProNova Solutions, LLC, ProTom International, Sumitomo Heavy Industries Ltd., and Varian Medical Systems.

Global Proton Therapy Market: Key Developments

Major players in the market are focused on establishing proton therapy center to enhance their market share. For instance, in November 2019, Mevion Medical Systems signed an agreement with Tianjin Port Free Trade Zone Administrative Committee and Tianyi Holdings to develop a proton therapy center in Tianjin, China.

Major players in the market are also focused on expanding their customer base. For instance, in August 2019, Ion Beam Applications S.A. signed a formal contract with the Institute for Basic Science to install a Cyclone 70 system in Daejeon, South Korea.

Segmentation

Scope of the report

  • Proton Therapy Market, By Set up Type:
    • Single Room
    • Multiple Room
  • Proton Therapy Market, By Indication:
    • Head & Neck Cancer
    • Brain Cancer
    • Sarcoma
    • Pediatric Cancer
    • Gastro-intestinal Cancer
    • Prostate Cancer
    • Lung Cancer
  • Proton Therapy Market, By Region:
    • North America
      • By Set up Type:
        • Single Room
        • Multiple Room
      • By Indication
        • Head & Neck Cancer
        • Brain Cancer
        • Sarcoma
        • Pediatric Cancer
        • Gastro-intestinal Cancer
        • Prostate Cancer
        • Lung Cancer
      • By Country:
        • S.
        • Canada
      • Latin America
        • By Set up Type:
          • Single Room
          • Multiple Room
        • By Indication
          • Head & Neck Cancer
          • Brain Cancer
          • Sarcoma
          • Pediatric Cancer
          • Gastro-intestinal Cancer
          • Prostate Cancer
          • Lung Cancer
        • By Country:
          • Brazil
          • Mexico
          • Argentina
          • Rest of Latin America
        • Europe
          • By Set up Type:
            • Single Room
            • Multiple Room
          • By Indication
            • Head & Neck Cancer
            • Brain Cancer
            • Sarcoma
            • Pediatric Cancer
            • Gastro-intestinal Cancer
            • Prostate Cancer
            • Lung Cancer
          • By Country:
            • Germany
            • K.
            • France
            • Italy
            • Spain
            • Russia
            • Rest of Europe
          • Asia Pacific
            • By Set up Type:
              • Single Room
              • Multiple Room
            • By Indication
              • Head & Neck Cancer
              • Brain Cancer
              • Sarcoma
              • Pediatric Cancer
              • Gastro-intestinal Cancer
              • Prostate Cancer
              • Lung Cancer
            • By Country:
              • China
              • India
              • Japan
              • Australia
              • South Korea
              • ASEAN
              • Rest of Asia Pacific
            • Middle East
              • By Set up Type:
                • Single Room
                • Multiple Room
              • By Indication
                • Head & Neck Cancer
                • Brain Cancer
                • Sarcoma
                • Pediatric Cancer
                • Gastro-intestinal Cancer
                • Prostate Cancer
                • Lung Cancer
              • By Country:
                • GCC
                • Israel
                • Rest of Middle East
              • Africa
                • By Set up Type:
                  • Single Room
                  • Multiple Room
                • By Indication
                  • Head & Neck Cancer
                  • Brain Cancer
                  • Sarcoma
                  • Pediatric Cancer
                  • Gastro-intestinal Cancer
                  • Prostate Cancer
                  • Lung Cancer
                • By Country:
                  • South Africa
                  • Central Africa
                  • North Africa
                • Company Profiles
                  • Hitachi Ltd. *
                    • Company Overview
                    • Product Portfolio
                    • Key Highlights
                    • Financial Overview
                    • Strategies
                  • Ion Beam Applications SA
                  • Mevion Medical Systems
                  • Mitsubishi Electric Corporation
                  • ProNova Solutions, LLC
                  • ProTom International
                  • Sumitomo Heavy Industries Ltd.
                  • Varian Medical Systems

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 14-Sep-2021